Intentional topiramate ingestion in an adolescent female

Annals of Pharmacotherapy

Volumn 38, Issue 9, 2004, Pages 1439-1442

  Chung, Allison M ^a,b   Reed, Michael D ^c  

^a AUBURN UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Speech impairment; Topiramate; Toxicity

Indexed keywords

ANOREXIGENIC AGENT; TOPIRAMATE;

ADOLESCENT; AGGRESSION; ANOREXIA; ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM; CONFUSION; DISORIENTATION; DRUG ABUSE; DRUG INTOXICATION; ECHOLALIA; FEMALE; HUMAN; MENTAL DISEASE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SPEECH DISORDER; SYMPTOMATOLOGY;

ADOLESCENT; ANTICONVULSANTS; CONFUSION; FEMALE; FRUCTOSE; HUMANS; OVERDOSE; SPEECH DISORDERS; TABLETS;

EID: 4143092462     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D572     Document Type: Article

References (27)

1. Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 2000;41(suppl 1):S3-9.
2. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res 1997;28:167-79.
3. Petroff OA, Hyder F, Rothman DL, Mattson RH. Topiramate rapidly raises brain GABA in epilepsy patients. Epilepsia 2001;42:543-8.
4. Taverna S, Sancini G, Mantegazza M, Franceschetti S, Avanzini G. Inhibition of transient and persistent Na+ current fractions by the new anti-convulsant topiramate. J Pharmacol Exp Ther 1999;288:960-8.
5. DeLorenzo RJ, Sombati S, Coulter DA. Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons. Epilepsia 2000;41(suppl 1):S40-4.
6. Gibbs JW 3rd, Sombati S, DeLorenzo RJ, Coulter DA. Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 2000;41(suppl 1):S10-6.
7. Dodgson SJ, Shank RP, Maryanoff BE. Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 2000;41(suppl 1):S35-9.
8. Package insert. Topomax (topiramate) tablets and sprinkle capsules. Raritan, NJ: Ortho-McNeil Pharmaceuticals, 2001.
9. Langtry HD, Gillis JC, Davis R. Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. Drugs 1997;54:752-73.
10. Doose DR, Walker SA, Gisclon LG, Nayak RK. Single-dose pharmacokinetics and effect of food on the bioavailability of topiramate, a novel antiepileptic drug. J Clin Pharmacol 1996;36:884-91.
11. Ormrod D, McClellan K. Topiramate: a review of its use in childhood epilepsy. Paediatr Drugs 2001;3:293-319.
12. Perucca E. A pharmacological and clinical review on topiramate, a new antiepileptic drug. Pharmacol Res 1997;35:241-56.
13. Sachdeo RC. Topiramate. Clinical profile in epilepsy. Clin Pharmacokinet 1998;34:335-46.
14. Jones MW. Topiramate - safety and tolerability. Can J Neurol Sci 1998;25:S13-5.
15. Philippi H, Boor R, Reitter B. Topiramate and metabolic acidosis in infants and toddlers. Epilepsia 2002;43:744-7.
16. Rosenfeld WE, Doose DR, Walker SA, Baldassarre JS, Reife RA. A study of topiramate pharmacokinetics and tolerability in children with epilepsy. Pediatr Neurol 1999;20:339-44.
17. Levisohn PM. Safety and tolerability of topiramate in children. J Child Neural 2000;15(suppl 1):S22-6.
18. Longin E, Teich M, Koelfen W, Konig S. Topiramate enhances the risk of valproate-associated side effects in three children. Epilepsia 2002;43:451-4.
19. Sachdeo RC, Sachdeo SK, Walker SA, Kramer LD, Nayak RK, Doose DR. Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy. Epilepsia 1996;37:774-80.
20. Ko CH, Kong CK. Topiramate-induced metabolic acidosis: report of two cases. Dev Med Child Neurol 2001;43:701-4.
21. Takeoka M, Holmes GL, Thiele E, Bourgeois BF, Helmers SL, Duffy FH, et al. Topiramate and metabolic acidosis in pediatric epilepsy. Epilepsia 2001;42:387-92.
22. Traub S, Howland MA, Hoffman RS, Nelson LS. Neurological changes after ingestion of topiramate (abstract). J Toxicol Clin Toxicol 2002;40:620.
23. Smith AG, Brauer HR, Catalano G, Catalano MC. Topiramate overdose: a case report and literature review. Epilepsy Behav 2001;2:603-7.
24. Fakhoury T, Murray L, Seger D, McLean M, Abou-Khalil B. Topiramate overdose: clinical and laboratory features. Epilepsy Behav 2002;3:185-9.
25. Kemmerer D, Simone K, Tomassoni A. Non-anion gap metabolic acidosis associated with acute or chronic topiramate overdose (abstract). J Toxicol Clin Toxicol 2002;40:691.
26. Colom F, Vieta E, Benabarre A, Martinez-Aran A, Reinares M, Corbella B, et al. Topiramate abuse in a bipolar patient with an eating disorder. J Clin Psychiatry 2001;62:475-6.
27. Garnett WR. Clinical pharmacology of topiramate: a review. Epilepsia 2000;41(suppl 1):S61-5.